Alembic Pharmaceuticals informs about press release

09 Mar 2023 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg. In this regard, the company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1045.05 -9.95 (-0.94%)
23-Dec-2024 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.85
Dr. Reddys Lab 1341.35
Cipla 1476.05
Lupin 2156.45
Zydus Lifesciences 971.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.